Association of the glycogen synthase locus on 19q13 with NIDDM in Pima Indians

被引:0
|
作者
Majer, M
Mott, DM
Mochizuki, H
Rowles, JC
Pedersen, O
Knowler, WC
Bogardus, C
Prochazka, M
机构
[1] NIDDKD,NIH,CLIN DIABET & NUTR SECT,PHOENIX,AZ 85016
[2] NIDDKD,NIH,DIABET & ARTHRITIS EPIDEMIOL SECT,PHOENIX,AZ 85016
[3] STENO DIABET CTR,GENTOFTE,DENMARK
关键词
non-insulin-dependent diabetes mellitus; insulin resistance; skeletal muscle glycogen synthase gene; association; Pima Indians;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Skeletal muscle glycogen synthase (encoded by GYS1 on chromosome 19q13.3) is the rate-limiting enzyme in insulin-mediated non-oxidative glucose disposal. Our previous studies have demonstrated an impairment of insulin-stimulated GYS1 activities in insulin-resistant Pima Indians, and associations of non-insulin-dependent diabetes mellitus (NIDDM) with the GYS1 locus were reported recently in Finnish and Japanese populations. We have performed linkage and association analyses of GYS1 and seven additional DNA markers on 19q with NIDDM, and with parameters of insulin action in the Pima Indians. We have found a significant association of NIDDM with GYS1 genotypes (p = 0.009), and with common GYS1 alleles (p = 0.022) in the Pima Indians. We have performed a detailed comparative analysis of the GYS1 gene, mRNA, and protein product in insulin-sensitive and insulin-resistant Pima Indians. No mutations in GYS1 coding sequences were detected; nor did we find alterations of CYS1 mRNA expression or of its basal enzymatic activity in insulin-resistant Pima Indians. These results contrasted with a 25% reduction of immunoreactive protein in insulin-resistant subjects as detected by Western blotting with an antibody specific for the C-terminal end of GYS1 (t-test p = 0.024; Wilcoxon's ranksum test, p = 0.04). Because no mutations were detected in the DNA encoding this epitope, the difference in immunoreactivity may reflect post-translational modification(s) of the protein rather than a difference in the gene itself, or it could have occurred by chance, We conclude that our data do not indicate alterations in the GYS1 gene as the cause for the observed association, and that a different locus near GYS1 may be the contributing genetic element.
引用
收藏
页码:314 / 321
页数:8
相关论文
共 50 条
  • [41] A follow-up study of chromosome 19q13 in multiple sclerosis susceptibility
    Bonetti, Alessandro
    Koivisto, Keijo
    Pirttila, Tuula
    Elovaara, Irina
    Reunanen, Mauri
    Laaksonen, Mikko
    Ruutiainen, Juhani
    Peltonen, Leena
    Rantamaki, Terhi
    Tienari, Pentti J.
    JOURNAL OF NEUROIMMUNOLOGY, 2009, 208 (1-2) : 119 - 124
  • [42] Rapid-onset dystonia-parkinsonism: Linkage to chromosome 19q13
    Kramer, PL
    Mineta, M
    Klein, C
    Schilling, K
    de Leon, D
    Farlow, MR
    Breakefield, XO
    Bressman, SB
    Dobyns, WB
    Ozelius, LJ
    Brashear, A
    ANNALS OF NEUROLOGY, 1999, 46 (02) : 176 - 182
  • [43] Localization of familial benign hypercalcemia, Oklahoma variant (FBHOk), to chromosome 19q13
    Lloyd, SE
    Pannett, AAJ
    Dixon, PH
    Whyte, MP
    Thakker, RV
    AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 64 (01) : 189 - 195
  • [44] No evidence for a role of SLC7A10 in 19q13 in the etiology of cystinuria
    Schmidt, C
    Vester, U
    Zerres, K
    Eggermann, T
    CLINICAL NEPHROLOGY, 2004, 62 (01) : 71 - 73
  • [45] ALTERATIONS OF THE RRAS AND ERCC1 GENES AT 19Q13 IN GEMISTOCYTIC ASTROCYTOMAS
    Ohta, T.
    Yachi, K.
    Fukushima, T.
    Watanabe, T.
    Ohgaki, H.
    NEURO-ONCOLOGY, 2016, 18 : 59 - 60
  • [46] Search for mutations in SLC1A5 (19q13) in cystinuria patients
    Brauers, E
    Vester, U
    Zerres, K
    Eggermann, T
    JOURNAL OF INHERITED METABOLIC DISEASE, 2005, 28 (06) : 1169 - 1171
  • [47] Somatic mosaicism and variable expressivity in Diamond Blackfan anemia (DBA): A large deletion involving the 19q13 locus in a patient with transient anemia
    Garelli, E
    Quarello, P
    Campagnoli, M
    Brusco, A
    Carando, A
    Menegatti, E
    Crescenzio, N
    Foglia, L
    Dianzani, I
    Ramenghi, U
    BLOOD, 2005, 106 (11) : 991A - 991A
  • [48] Alterations of the RRAS and ERCC1 Genes at 19q13 in Gemistocytic Astrocytomas
    Ohta, Takashi
    Kim, Young-Ho
    Oh, Ji-Eun
    Satomi, Kaishi
    Nonoguchi, Naosuke
    Keyvani, Kathy
    Pierscianek, Daniela
    Sure, Ulrich
    Mittelbronn, Michel
    Paulus, Werner
    Vital, Anne
    Yokoo, Hideaki
    McDonald, Kerrie
    Kleihues, Paul
    Nazaret, Nicolas
    Barbet, Fabienne
    Lachuer, Joel
    Ohgaki, Hiroko
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2014, 73 (10): : 908 - 915
  • [49] Pleiotropic QTL on chromosome 19q13 for triglycerides and adiposity: The HERITAGE family study
    Feitosa, MF
    Rice, T
    North, KE
    Kraja, A
    Rankinen, T
    Leon, AS
    Skinner, JS
    Blangero, J
    Bouchard, C
    Rao, DC
    ATHEROSCLEROSIS, 2006, 185 (02) : 426 - 432
  • [50] Does APOE explain the linkage of Alzheimer's disease to chromosome 19q13?
    Blom, Elin S.
    Holmans, Peter
    Arepalli, Sampath
    Adighibe, Omanma
    Hamshere, Marian L.
    Gatz, Margaret
    Pedersen, Nancy L.
    Bergem, A. L. Mina
    Owen, Michael J.
    Hollingworth, Paul
    Goate, Alison
    Williams, Julie
    Lannfelt, Lars
    Hardy, John
    Vrieze, Fabienne Wavrant-De
    Glaser, Anna
    AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2008, 147B (06) : 778 - 783